$ROG-CH News

Last published 7mo ago

7mo ago.FTSE AZN-GB ROG-CH SAN-FRAstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failedCNBCThe experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
9mo agoMETA MSFT TSLA .SPX+8CNBC Daily Open: Investors expected the Fed to hold rates — it was Powell's comments that drew interestCNBCPowell left some advice to the next Fed chair. "Don't get pulled into elected politics," Powell said. "Don't do it."
10mo agoLLY ABVX-FR .STOXX FRES-GB+3A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last yearCNBCEurope's best performing stock in 2025, Abivax, could be snapped up any day now, analysts say.
11mo agoLLY ROG-CH AZN-GB AMGN+3Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, LillyCNBCGrowing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more weight loss medicines near market entry.
1y agoLLY ROG-CH ABBV NVO+1Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in studyCNBCThe highest dose of Eli Lilly's weekly injection helped patients with obesity or who are overweight lose 20.1% of their body weight on average at 48 weeks.
1y agoROG-CH AMZN PFE AZNGenentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakersCNBCThe program will sell Xofluza through three pharmacies with a $50 cash pay option, which is 70% lower than the pill's current list price before insurance.
1y agoPFE LLY JNJ AZN+5Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakersCNBCPfizer's deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar agreements that would make them immune to tariffs.
1y agoROG-CH NVO LLY ZEAL-DKRoche targets becoming top 3 obesity player as experimental drug enters late-stage trialCNBCRoche Pharmaceuticals' CEO told investors she was "serious" about the goal of becoming a top 3 obesity player.
1y agoNVO LLY AZN-GB PFE+4A world on weight loss drugs: How GLP-1s are reshaping the economyCNBCAs GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for both health outcomes and the economy.
1y agoLLY NVO PFE VKTX+4Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investorsCNBCEli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions and easier manufacturing.
1y agoNVO LLY AMGN ROG-CH+4Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakersCNBCThe Trump administration is planning to pilot covering weight loss drugs. A longtime healthcare exec moves to a strategic advisory role at General Catalyst.
1y agoABBV BMY LLY NVS+14Trump's pharmaceutical tariffs could affect some drugmakers more than othersCNBCAbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.
1y agoVRTX GILD ROG-CH JNJ+3Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than othersCNBCTrump's "big beautiful" bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of digital health funding this year.
1y agoMRK ABBV LLY JNJ+4Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loomCNBCTariff threats are fueling a new wave of U.S. manufacturing investments from the pharmaceutical industry.
1y agoMRK PFE ROG-CH NVO+1Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing dealCNBCMerck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.
1y agoNVO LLY ROG-CHHealthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closingCNBCNovo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to oppose confirmation of RFK Jr.
2y agoNVS NVO LLY ROG-CH+1Novartis not joining the 'frenzy' of weight loss drugs, CEO saysCNBCSwiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
2y agoAMZN ROG-CH RHHBF JNJ+1Roche alleges counterfeit diabetes medical devices were sold on AmazonCNBCCounterfeit diabetes test strips have been sold on Amazon and shipped to patients across the U.S., said biotech company Roche.
2y agoROG-CH NVO LLYRoche says weight loss drug shows promising results in early trialCNBCThe weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after 24 weeks in the phase one trial.
2y ago.STOXX GS GSK-GB ROG-CH+4The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisonsCNBCOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday.
2y ago.STOXX GS GSK-GB ROG-CH+4The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisonsCNBCOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a record-high close on Friday.
2y agoNVO NOVO.B-DK LLY AMGN+4Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change thatCNBCNovo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize on the success of their drugs.
2y agoVKTX TERN undefined NOVO.B-DK+8The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming spaceCNBCWall Street has been focused on Novo Nordisk, Eli Lilly and other large drugmakers hoping to join the weight loss drug market, such as Pfizer, Roche and Amgen.
2y agoPFE NOVO.B-DK LLY AMGN+4The weight loss drug boom isn't over yet — here's what to expect in the year aheadCNBC2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance coverage and unpleasant side effects.
2y agoROG-CHRoche enters obesity market with Carmot takeover but drugs may not be available until 2030CNBCRoche is to acquire anti obesity drug developer Carmot Therapeutics, becoming the latest pharma company to enter the global weight-loss drugs market.
3y agoNVDA RXRX ROG-CH BAYN-DE+4Nvidia invests $50 million in biotech company Recursion for AI drug discoveryCNBCNvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.
3y agoREGN ROG-CHRegeneron shares fall after FDA rejects high-dose eye disease treatmentCNBCRegeneron said the rejection was "solely due to an ongoing review of inspection findings at a third-party filler."
4y agoBDX TMO SAN-FR ROG-CHThe at-home testing industry, from Covid to cancer, may be worth over $2 billion by 2025CNBCThe emerging marketplace of consumer-initiated lab testing may be worth more than $2 billion by 2025, according to Quest Diagnostics.
5y agoAMZN NAUT TMO ROG-CH+3Amazon invested millions in a pre-revenue company with a system for measuring human proteinsCNBCAmazon declined to specify whether it's working with Nautilus Technology in addition to investing. The online retailer has been pushing into health care.
5y agoROG-CH GILD PFE MRNA+2Roche arthritis drug reduces death in hospitalized patients with severe Covid, Oxford researchers sayCNBCTocilizumab appears to reduce the risk of death in hospitalized patients with severe Covid-19, researchers at the University of Oxford said
5y agoLH MRNA PFE BNTX+1LabCorp CEO says Covid vaccine recipients don't need to be tested for antibodies afterwardCNBC"We still have to understand a lot more about the vaccines, know what to measure, how to measure," LabCorp CEO Adam Schechter told CNBC.
5y agoROG-CHJapan's Chugai soars 7% after UK says its drug reduces hospital time for Covid patientsCNBCThe U.K. said patients receiving the drugs, typically used to treat rheumatoid arthritis, "left intensive care between 7 to 10 days earlier on average."
5y agoGILD BNTX PFE ROG-CHGilead CEO expects remdesivir to effectively treat Covid strains found in U.K., South AfricaCNBC"I expect remdesivir with these variants will continue to make an impact on patients," Gilead Sciences CEO Daniel O'Day told CNBC.
5y agoRLF-CH ROG-CH GILD LLYA Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this yearCNBCSwiss biotech firm Relief Therapeutics has seen its share price climb by nearly 38,000% so far this year, as it develops a drug focused on respiratory failure arising from severe Covid-19.
6y agoREGN LLY GILD ROG-CH+1Dr. Scott Gottlieb: Antibody drugs may be helpful virus treatments, but won't end U.S. epidemicCNBC"This is not going to end the epidemic. This is not going to be wildly available to everyone," Dr. Scott Gottlieb told CNBC.
6y agoREGN ROG-CHRegeneron requests emergency approval for antibody treatment taken by Trump; stock rises 4% in pre-marketCNBCRegeneron's stock price rose over 4% in pre-market trade Thursday.
6y agoROG-CHRoche to launch new rapid coronavirus test in Europe later this month following regulatory clearanceCNBC"Especially in the upcoming flu season, it is important to know whether a person has SARS-CoV-2 or the flu to ensure the right course of treatment," Roche's CEO Thomas Schinecker said in a statement.
6y agoTGT LOW WMT HD+45 things to know before the stock market opens WednesdayCNBCThe S&P 500 was pacing to add to Tuesday's record close as Target and Lowe's reported blowout earnings.
6y agoABT ROG-CH TMOThe CDC 'let the country down' with coronavirus testing, White House trade adivsor Navarro saysCNBC"Early on in this crisis the CDC, which really had the most trusted brand around the world in this space, really let the country down with the testing," Navarro told NBC.
6y agoGILD REGN SAN-FR ROG-CHBioAegis says its 'inflammation regulator' is best weapon to fight Covid-19CNBCBioAegis Therapeutics is currently awaiting FDA approval to begin testing its plasma gelsolin therapy on Covid-19 patients. The company says its treatment prevents the damage caused by excess inflammation without suppressing the immune system and offers the best defense against the virus.
6y agoSRNE REGN SAN-FR ROG-CHSorrento Therapeutics and Mount Sinai join forces to develop Covid-19 antibody shieldCNBCSorrento Therapeutics and Mount Sinai Health System in New York City have joined forces to develop an antibody cocktail they hope will shield against Covid-19 infection for up to two months.
6y agoPFE ILMN ROG-CHDr. Scott Gottlieb on coronavirus antibody tests: 'I would repeat it three times' to make sureCNBC"I know they're expensive but I wouldn't put confidence in any one test," Dr. Scott Gottlieb told CNBC on Monday.
6y agoROG-CHCoronavirus live updates: Roche to invest in German testing site, CEO says recovered patients 'very likely' immuneCNBCCovid-19 has infected more than 3.5 million people around the world as of Monday, killing at least 247,752 people.
6y agoROG-CHRoche CEO says it is 'very likely' people develop immunity after recovering from coronavirusCNBCSeverin Schwan, chief executive of Roche, said he believed those who had already had the coronavirus would now be immune to the illness — but he pointed out that more research was required.
6y agoROG-CH REGN SAN-FR MRNA+4Pharma giants granted coronavirus approvals but doubts remain on manufacturing a global vaccineCNBCExperts warn that vaccine timelines look ambitious and argue more thought is needed on manufacturing.
6y agoBIIB GILD JNJ PFE+2The market is rebounding on hope for a treatment, new index tracking coronavirus-drug makers showsCNBCA new CNBC index that tracks companies working on a Covid-19 cure shows how closely the stock market is following drug equities.
6y agoGILD REGN SAN-FR ROG-CH+4'Science will come through': Doctor who pioneered HIV treatment discusses potential Covid-19 drugsCNBCDr. David Ho's lab pioneered treatment approaches to HIV. Now, his focus is Covid-19, or, more specifically, SARS-CoV-2, the virus that causes Covid-19.
6y agoLH ROG-CHQuest Diagnostics takes steps to shore up its balance sheet, ramps up coronavirus antibody testing as profit plungesCNBC"Quest has been at the tip of the spear in responding to this crisis, and we continue to play a critical role in the next phase of containing COVID-19," CEO Steve Rusckowski said.
6y agoHEIA-NL AKZA-NL RMS-FR ROG-CHEuropean markets head for positive open, defying coronavirus and oil price fearsCNBCEuropean markets are set to open in positive territory on Wednesday, bucking the trend in global markets where there are widespread concerns over the coronavirus outbreak and a slump in oil prices.
6y agoAAPL GOOGL FB GILD+1California Gov. Gavin Newsom says tech companies are key to lifting coronavirus restrictionsCNBC"If I was talking to you last year, the big debate in this state and by extension this country was the work California was doing to lead in the privacy space," he said.